omalizumab

Source:http://linkedlifedata.com/resource/umls/id/C0966225

NCI: A humanized monoclonal antibody directed against the C-epsilon 3 domain of immunoglobulin E. Olizumab binds to this IgE domain, thereby preventing IgE from binding to its high-affinity mast-cell receptor. (NCI04)

Download in:

View as